期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital 被引量:19
1
作者 Pasiri Sithinamsuwan Teerha Piratvisuth +2 位作者 Wiwatana Tanomkiat Nualta Apakupakul Surat Tongyoo 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第3期339-343,共5页
AIM To determine the clinical presentations,survival and prognostic factors of hepatocellularcarcinoma(HCC)in Southern Thailand.METHODS Retrospective analysis wasperformed on the 336 hepatocellular carcinomapatients... AIM To determine the clinical presentations,survival and prognostic factors of hepatocellularcarcinoma(HCC)in Southern Thailand.METHODS Retrospective analysis wasperformed on the 336 hepatocellular carcinomapatients treated at Songklanagarind hospitalbetween 1 January 1991 and 31 January 1999.RESULTS Of these 336 patients,276 weremales and 60 were females.The mean age was54.4 years.The common symptoms and signswere abdominal pain and hepatomegaly.Themost common presentation of tumor was adominant mass with daughter nodules.Portalvein involvement was found in 50% of total.Extrahepatic metastasis was found in 13%,andthe lung was the most common site.There were55.4% with evidence of cirrhosis and half ofthem were in Childs class B.HBsAg waspositive in 72.6%.Regarding Okuda’s tumorstaging,15%,61% and 24% were stage Ⅰ,Ⅱand Ⅲ,respectively.Overall median survivalwas 2.1 months(11.5,2.6 and 0.7 months forstage Ⅰ,Ⅱ and Ⅲ respectively).Treatments ofHCC improved patient survival(5.5 months vs1.6 months for untreated patients ).Mostcommon causes of death were hepatic failure.Using multivariate analysis,the prognostic factors identified were tumor staging,alpha-fetoprotein level above 10000μg·L<sup>-1</sup>extrahepatic metastasis,portal vein thrombosisand treatment.CONCLUSION HCC in Thailand is a fataldisease with poor outcome due to latepresentation and high prevalence of livercirrhosis.Early detection and propermanagement may improve outcome. 展开更多
关键词 hepatoma/therapy BIOPSY NEOPLASM STAGING survival analysis NEOPLASMS metastasis prognosis drug therapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部